This announcement is a separate document:
复星医药关于增持复星凯特生物科技有限公司股权及修订及重述许可协议的公告
Announcement of Fosun Pharmaceutical on increasing the shareholding of Fosun Kate Biotechnology Co., Ltd. and revising and restating the license agreement
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.